German deeptech firm Orbem is using AI-powered MRI technology to scan biological samples in food, construction and medical environments.
Orbem has raised €86M across 2 funding rounds from 20 investors, most recently a Series B round in Jan 2026. Based in Berlin, Germany; active in Deeptech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-01-20 | Series B | €56M | 83North,Angel Investors,existing backers,General Catalyst,Innovation Industries,Possible Ventures+2 more | View deal → |
| 2023-10-11 | Series A | €30M | 83North,Bastian Nominacher,Dr. Alexander Hüttenbrink,Dr. Michael Ardelt,Dr. Oliver Trinchera,Dr. Rüdiger Schmidt+9 more | View deal → |
